Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan K Mathai

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 21, 2010
Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotypeSusan K Mathai, Mridu Gulati, Xueyan Peng, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2015
Desmoplakin Variants Are Associated with Idiopathic Pulmonary FibrosisSusan K Mathai, Brent S Pedersen, Keith Smith, et al.
Chest|December 5, 2022
Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function TrajectoryScott M Matson, Misbah Baqir, Teng Moua, et al.
Thorax|September 28, 2019
<i>MUC5B</i> variant is associated with visually and quantitatively detected preclinical pulmonary fibrosisSusan K Mathai, Stephen Humphries, Jonathan A Kropski, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 23, 2018
The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosisTsukasa Okamoto, Susan K Mathai, Corinne E Hennessy, et al.
Annals of the American Thoracic Society|March 2, 2017
Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary FibrosisAni Manichaikul, Li Sun, Alain C Borczuk, et al.
American Journal of Respiratory Cell and Molecular Biology|May 24, 2022
Aberrant Multiciliogenesis in Idiopathic Pulmonary FibrosisEunjoo Kim, Susan K Mathai, Ian T Stancil, et al.
Annals of the American Thoracic Society|June 19, 2026
Nintedanib in Post-COVID Interstitial Lung Disease: a double-blind, randomized, placebo-controlled Clinical TrialSusan K Mathai, Sean J Callahan, Helena Chang, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2022
Incidence and Progression of Fibrotic Lung Disease in an At-Risk CohortMark P Steele, Anna L Peljto, Susan K Mathai, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Idiopathic Pulmonary Fibrosis Risk Loci in East Asian Populations Mirror those of European PopulationsAnna L Peljto, Haruhiko Furusawa, Deepa Puthenvedu, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 21, 2010
Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotypeSusan K Mathai, Mridu Gulati, Xueyan Peng, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2015
Desmoplakin Variants Are Associated with Idiopathic Pulmonary FibrosisSusan K Mathai, Brent S Pedersen, Keith Smith, et al.
Chest|December 5, 2022
Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function TrajectoryScott M Matson, Misbah Baqir, Teng Moua, et al.
Thorax|September 28, 2019
<i>MUC5B</i> variant is associated with visually and quantitatively detected preclinical pulmonary fibrosisSusan K Mathai, Stephen Humphries, Jonathan A Kropski, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 23, 2018
The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosisTsukasa Okamoto, Susan K Mathai, Corinne E Hennessy, et al.
Annals of the American Thoracic Society|March 2, 2017
Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary FibrosisAni Manichaikul, Li Sun, Alain C Borczuk, et al.
American Journal of Respiratory Cell and Molecular Biology|May 24, 2022
Aberrant Multiciliogenesis in Idiopathic Pulmonary FibrosisEunjoo Kim, Susan K Mathai, Ian T Stancil, et al.
Annals of the American Thoracic Society|June 19, 2026
Nintedanib in Post-COVID Interstitial Lung Disease: a double-blind, randomized, placebo-controlled Clinical TrialSusan K Mathai, Sean J Callahan, Helena Chang, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2022
Incidence and Progression of Fibrotic Lung Disease in an At-Risk CohortMark P Steele, Anna L Peljto, Susan K Mathai, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Idiopathic Pulmonary Fibrosis Risk Loci in East Asian Populations Mirror those of European PopulationsAnna L Peljto, Haruhiko Furusawa, Deepa Puthenvedu, et al.
Pageof 5